Pu Wang
No. 3-11. Wenhua Road
Shenyang, 110819, China
Shenyang, 110819, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Targeting the C5-C5aR1 axis: A promising therapeutic strategy for Alzheimer's disease and amyotrophic lateral sclerosis by unlocking neuroprotection.
Journal: Biochemical pharmacology
Published: September 02, 2025
Aspirin Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Inhibiting the Activities of Microglia in a NF-κB-dependent Complement System-deactivating Mechanism.
Journal: Molecular neurobiology
Published: July 07, 2025
Retraction Note: The role of cyclooxygenase-2, interleukin-1β and fibroblast growth factor-2 in the activation of matrix metalloproteinase-1 in sheared-chondrocytes and articular cartilage.
Journal: Scientific reports
Published: April 08, 2025
Triptolide induces the secretion of insulin, through which it alleviates the tauopathies of Alzheimer's disease via inhibiting the phosphorylation of tau.
Journal: Biochemical pharmacology
Published: February 12, 2025
Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer's disease.
Journal: Neuroscience and biobehavioral reviews
Published: May 10, 2024
Natural polyphenols as novel interventions for aging and age-related diseases: Exploring efficacy, mechanisms of action and implications for future research.
Journal: Chinese herbal medicines
Published: November 09, 2023
The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.
Journal: Molecular neurobiology
Published: October 16, 2022
As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: August 11, 2022
Meloxicam Inhibits Apoptosis in Neurons by Deactivating Tumor Necrosis Factor Receptor Superfamily Member 25, Leading to the Decreased Cleavage of DNA Fragmentation Factor Subunit α in Alzheimer's Disease.
Journal: Molecular neurobiology
Published: August 09, 2022
Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons.
Journal: Frontiers in molecular neuroscience
Published: July 29, 2022
Last Updated: 09/26/2026